Top Back to top

Clinical and immunological outcome of CID patients with hypomorphic RAG mutations following HSCT

Study number:
8427016
Short title:
RAG
Study status:
Data collection
Deadline for data collection:
Study design:
 
Primary objective:
 
Key inclusion criteria:
Data are collected from any transplanted RAG 1/2 deficient patient who presented with >300 T-cells independent of age. Data collection will include detailed information prior HSCT (clinical, genetic and immunological).

Exclusion criteria, besides classical SCID patients, are Omenn phenotype and T-cells due to materno-fetal transfusion, or patients not having been treated by HSCT.

If you wish to participate in this study and have not been contacted by the data office please contact: iewpebmt@lumc.nl
Country:
 
Principal investigator:
Catharina Schuetz & Benedicte Neven
Principal investigator email:
 
EBMT Study coordinator:
Sheree Hazelaar
Study coordinator email:
iewpebmt@lumc.nl